| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/07/1999 | WO1999000146A1 Development and use of human pancreatic cell lines |
| 01/07/1999 | WO1999000010A2 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998044141A3 Insect expression vectors |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | WO1998039027A3 Sialyl lewis antigens as targets for immunotherapy |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889125A1 Monoclonal antibody 4G8b4b12 to human FLT3/FLK2 |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889054A2 Antibody 67D2 against CD164 |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888551A1 Method for predicting the outcome of hepatitis b infection |
| 01/07/1999 | EP0888461A1 Tissue remodeling proteins |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0888046A1 Method of protein production using mitochondrial translation system |
| 01/07/1999 | EP0784632B1 Process for extracting high-purity von willebrand factor |
| 01/07/1999 | EP0672127B1 Use of thiol redox proteins for reducing disulfide bonds |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | EP0646015B1 Contraceptive vaccine |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | CA2427749A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 01/07/1999 | CA2295326A1 Cardiotrophin-like cytokine |
| 01/07/1999 | CA2295318A1 Human extracellular matrix proteins |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2294704A1 Protein that binds trail |
| 01/07/1999 | CA2294604A1 Transgenic animals expressing human fc receptors |
| 01/07/1999 | CA2292379A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 01/06/1999 | CN1204370A A funguns wherein areA, pepC and/or pepE genes have been inactivated |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1203922A Humanized anti-human fas antibody |
| 01/06/1999 | CN1203921A Membrane protein polypeptide having pre-B cell growth-supporting ability and gene thereof |
| 01/05/1999 | US5856449 Glycoprotein |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 01/05/1999 | US5856301 Administering polypeptide |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
| 01/05/1999 | US5856296 DNA encoding interleukin-4 receptors |
| 01/05/1999 | US5856201 Methods of detection using a cellulose binding domain fusion product |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856182 Monoclonal antibodies specific for the PSA-ACT complex |
| 01/05/1999 | US5856179 Polypeptide production in animal cell culture |
| 01/05/1999 | US5856171 Cell death regulators |
| 01/05/1999 | US5856162 Receptor-type phosphotyrosine phosphatase-κ |
| 01/05/1999 | US5856151 Antifungal preparations containing osmotin |
| 01/05/1999 | US5856142 Periplasmic expression enables recombinant proteins which are, in principle, correctly folded to be obtained directly in a space protected from the environment. |
| 01/05/1999 | US5856141 Irradiating to form hybrid |
| 01/05/1999 | US5856140 Human interleukin-2 response blocker |
| 01/05/1999 | US5856138 Human parathyroid hormone muteins and production thereof |
| 01/05/1999 | US5856135 Reshaped human antibody to human interleukin-6 |
| 01/05/1999 | US5856134 Polypeptide antigens which are immunoreactive with sera from individuals having a non-a, non-b, non-c, non-d, non-e hepatitis. |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856123 Expression of polypeptides in yeast |
| 01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | US5855889 Polypeptide antibody |
| 01/05/1999 | US5855888 Monoclonal antibody which recognizes specifically extracellular region of human vla-2, .alpha. chain. the above drug for the treatment can suppress swelling with low toxicity |
| 01/05/1999 | US5855886 Immunoassay method involving fewer, preferably only one, reaction steps than conventional immunoassay in a therapeutic application, two prodrugs may be released which only become active for treatment when both are present. |
| 01/05/1999 | US5855866 Constructs designed to have a cytotoxic or otherwise anticellular effect against tumor vasculature |
| 01/05/1999 | CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus |
| 01/05/1999 | CA1340301C Vaccines against animal parasitic nematodes |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 01/01/1999 | CA2236459A1 Novel compounds |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 01/01/1999 | CA2236425A1 Gida1 |
| 01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
| 12/30/1998 | WO1998059248A1 Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
| 12/30/1998 | WO1998059246A1 C-peptide specific assay procedure |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998059059A1 Expression system for production of therapeutic proteins |
| 12/30/1998 | WO1998059058A2 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 12/30/1998 | WO1998059049A1 Reagents and methods useful for detecting diseases of the breast |
| 12/30/1998 | WO1998059047A1 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 12/30/1998 | WO1998059036A1 Composition having nematicidal activity |
| 12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
| 12/30/1998 | WO1998058963A1 Method for producing polyclonal and monoclonal antibodies |
| 12/30/1998 | WO1998058957A2 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 12/30/1998 | WO1998058618A2 Composition having nematicidal activity |
| 12/30/1998 | EP0887417A2 Method of producing a 19P2 ligand by cleavage of a fusion protein containing it |
| 12/30/1998 | EP0887415A2 Human RCE1 |